How to buy Henry Schein stock (HSIC)

Henry Schein is a medical distribution business based in the US. Henry Schein shares (HSIC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $69.82 – a decrease of 8.85% over the previous week. Henry Schein employs 26,000 staff and has a trailing 12-month revenue of around $12.5 billion.

Our top picks for where to buy Henry Schein stock

Buy Henry Schein stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Henry Schein stock price (NASDAQ: HSIC)

Use our graph to track the performance of HSIC stocks over time.

Henry Schein shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$69.82
52-week range	$63.67 - $82.63
50-day moving average more info button	$72.27
200-day moving average more info button	$70.90
Wall St. target price	$74.83
PE ratio more info button	28.9385
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$2.44

Is it a good time to buy Henry Schein stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Henry Schein price performance over time

Historical closes compared with the close of $68.95 from 2024-12-19

1 week (2024-12-13)	-9.99%
1 month (2024-11-21)	-6.53%
3 months (2024-09-20)	-3.09%
6 months (2024-06-21)	2.51%

1 year (2023-12-21)	-8.05%
2 years (2022-12-21)	-14.89%
3 years (2021-12-21)	72.96
5 years (2019-12-20)	3.44%

Is Henry Schein stock undervalued or overvalued?

Valuing Henry Schein stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Henry Schein's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Henry Schein's P/E ratio

Henry Schein's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 29x. In other words, Henry Schein shares trade at around 29x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Henry Schein's PEG ratio

Henry Schein's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6239. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Henry Schein's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Henry Schein's EBITDA

Henry Schein's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $922 million.

The EBITDA is a measure of a Henry Schein's overall financial performance and is widely used to measure a its profitability.

Henry Schein financials

Revenue TTM	$12.5 billion
Operating margin TTM	6.55%
Gross profit TTM	$3.8 billion
Return on assets TTM	3.88%
Return on equity TTM	6.33%
Profit margin	2.51%
Book value	$27.99
Market Capitalization more info button	$8.8 billion

TTM: trailing 12 months

Henry Schein share dividends

We're not expecting Henry Schein to pay a dividend over the next 12 months.

Have Henry Schein's shares ever split?

Henry Schein's shares were split on a 1275:1000 basis on 7 February 2019 . So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1275 shares. This wouldn't directly have changed the overall worth of your Henry Schein shares – just the quantity. However, indirectly, the new 21.6% lower share price could have impacted the market appetite for Henry Schein shares which in turn could have impacted Henry Schein's share price.

Henry Schein share price volatility

Over the last 12 months, Henry Schein's shares have ranged in value from as little as $63.67 up to $82.63. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Henry Schein's is 0.867. This would suggest that Henry Schein's shares are less volatile than average (for this exchange).

Henry Schein overview

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc.

Frequently asked questions

null
What percentage of Henry Schein is owned by insiders or institutions?
Currently 0.899% of Henry Schein shares are held by insiders and 107.432% by institutions. How many people work for Henry Schein?
Latest data suggests 26,000 work at Henry Schein. When does the fiscal year end for Henry Schein?
Henry Schein's fiscal year ends in December. Where is Henry Schein based?
Henry Schein's address is: 135 Duryea Road, Melville, NY, United States, 11747 What is Henry Schein's ISIN number?
Henry Schein's international securities identification number is: US8064071025 What is Henry Schein's CUSIP number?
Henry Schein's Committee on Uniform Securities Identification Procedures number is: 806407102